SE392271B - Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan

Info

Publication number
SE392271B
SE392271B SE7603651A SE7603651A SE392271B SE 392271 B SE392271 B SE 392271B SE 7603651 A SE7603651 A SE 7603651A SE 7603651 A SE7603651 A SE 7603651A SE 392271 B SE392271 B SE 392271B
Authority
SE
Sweden
Prior art keywords
derivatives
trimetoxybenzoyl
trimethoxybenzoyloxy
alkyl
procedure
Prior art date
Application number
SE7603651A
Other languages
English (en)
Other versions
SE7603651L (sv
Inventor
H Kato
T Nishikawa
T Mouri
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Priority to SE7603651A priority Critical patent/SE392271B/sv
Publication of SE7603651L publication Critical patent/SE7603651L/sv
Publication of SE392271B publication Critical patent/SE392271B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7603651A 1976-03-25 1976-03-25 Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan SE392271B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7603651A SE392271B (sv) 1976-03-25 1976-03-25 Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7603651A SE392271B (sv) 1976-03-25 1976-03-25 Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan

Publications (2)

Publication Number Publication Date
SE7603651L SE7603651L (sv) 1976-03-25
SE392271B true SE392271B (sv) 1977-03-21

Family

ID=20327393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603651A SE392271B (sv) 1976-03-25 1976-03-25 Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan

Country Status (1)

Country Link
SE (1) SE392271B (sv)

Also Published As

Publication number Publication date
SE7603651L (sv) 1976-03-25

Similar Documents

Publication Publication Date Title
SE437022B (sv) Forfarande for framstellning av n-substituerade morfolinderivat respektive piperidinderivat
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO148150C (no) Analogifremstilling av terapeutisk aktive piperazinderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
SE431333B (sv) Analogiforfarande for framstellning av piperazin- och piperidinderivat
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO774126L (no) Fremgangsmaate for fremstilling av tiazolidin- og tiazanderivater
FI773738A (fi) Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat
NO800664L (no) Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
NO145951C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater
NO148524C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater av guanidin
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE414633B (sv) Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
NO146710C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
FI790320A (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
SE392271B (sv) Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan